Cargando…
Reduction in proteinuria after immunosuppressive therapy and long-term kidney outcomes in patients with immunoglobulin A nephropathy
BACKGROUND/AIMS: Despite controversy regarding the benefits of immunosuppressive therapy in immunoglobulin A nephropathy (IgAN), clinical outcomes may vary depending on the patient’s responsiveness to this therapy. This study evaluated long-term kidney outcomes according to the extent of proteinuria...
Autores principales: | Kang, Shin Chan, Kim, Hyung Woo, Chang, Tae Ik, Kang, Ea Wha, Lim, Beom Jin, Park, Jung Tak, Yoo, Tae-Hyun, Jeong, Hyeon Joo, Kang, Shin-Wook, Han, Seung Hyeok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association of Internal Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435500/ https://www.ncbi.nlm.nih.gov/pubmed/33561333 http://dx.doi.org/10.3904/kjim.2020.240 |
Ejemplares similares
-
Optimal Proteinuria Target for Renoprotection in Patients with IgA Nephropathy
por: Nam, Ki Heon, et al.
Publicado: (2014) -
Determination of the optimal target level of proteinuria in the management of patients with glomerular diseases by using different definitions of proteinuria
por: Kee, Youn Kyung, et al.
Publicado: (2017) -
Immunoglobulin A Nephropathy Associated with Plasmodium falciparum Malaria
por: Yoo, Dong Eun, et al.
Publicado: (2012) -
External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy
por: Joo, Young Su, et al.
Publicado: (2022) -
Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial
por: Park, Kyoung Sook, et al.
Publicado: (2021)